Article Text

other Versions

PDF
Expression of thymoproteasome subunit β5t in type AB thymoma
  1. Yosuke Yamada1,2,
  2. Utano Tomaru2,
  3. Akihiro Ishizu3,
  4. Takayuki Kiuchi2,
  5. Masanori Kasahara2,
  6. Yoshihiro Matsuno1
  1. 1Department of Surgical Pathology, Hokkaido University Hospital, Sapporo, Japan
  2. 2Department of Pathology, Hokkaido University Graduate School of Medicine, Sapporo, Japan
  3. 3Health Sciences, Hokkaido University, Sapporo, Japan
  1. Correspondence to Dr Utano Tomaru, Department of Pathology, Hokkaido University Graduate School of Medicine, Kita-15, Nishi-7, Kita-ku, Sapporo 060-8638, Japan; tomaruu{at}med.hokudai.ac.jp

Abstract

Type AB thymoma is a thymic epithelial tumour composed of lymphocyte-poor type A and lymphocyte-rich type B components. Although it is categorised as a single entity in the classification of WHO, it shows a broad range of morphology. To investigate whether the functional characteristic of neoplastic cells in type AB thymoma relates to morphological diversity, we performed immunohistochemical analysis using anti-β5t antibody in 20 cases of type AB thymoma. β5t is a recently discovered proteasomal β subunit expressed exclusively in cortical thymic epithelial cells and tumour epithelial cells of thymomas with cortical differentiation. Consistent with our previous observation, β5t was predominantly expressed in the type B component. When the type B component was divided into three groups morphologically, β5t was expressed more frequently in cases with round to polygonal than spindle to oval tumour cells. Furthermore, the ratio of terminal deoxynucleotidyl transferase (TdT)-positive lymphocytes was increased in components with higher expression of β5t. These results indicate that the histological diversity of type AB thymoma correlates with expression of a functional marker β5t and abundance of TdT-positive lymphocytes.

  • Histopathology
  • Immunohistochemistry
  • Neoplasms
  • Tumour MarkerS

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.